Explore
← New search
Filters:
Duke University
✕
high
✕
metastatic melanoma patients, riaz et al. training cohort and combined validation cohorts
✕
clear all
1 matching publication(s)
Pathway signatures derived from on-treatment tumor specimens predict response to anti-PD1 blockade in metastatic melanoma.
PMID 34654806 · Nat Commun · 2021
L1
100/100